Teresa Quattrin
Buffalo, NYNPI 1881659753
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $198,663 of the $329,813 with a category attached, or 60.2%. Sanofi-aventis U.S. LLC accounts for 67.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $186,899, more than ten times the $1,980 reported in 2019.
Across 187 payments — averaging $1763.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$223K
- Sanofi US Services Inc.$41K
- Sanofi$28K
- Janssen Research & Development, LLC$23K
- Pfizer$11K
- Merck$3K
- plus $393 from 3 others
Across 242 payments — averaging $1521.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$100K
- Sanofi$57K
- Novo Nordisk AS$56K
- OPKO Pharmaceuticals, LLC$53K
- Sanofi US Services Inc.$40K
- Janssen Research & Development, LLC$37K
- plus $24K from 2 others
What the payments were for
- Consulting fees$83,64125%
- Speaking & faculty fees$198,66360%
- Travel & lodging$42,78713%
- Food & beverage$4,7231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 138 | $223,410 |
| Sanofi US Services Inc. | 16 | $40,678 |
| Sanofi | 12 | $28,116 |
| Janssen Research & Development, LLC | 4 | $23,083 |
| Pfizer | 13 | $10,834 |
| Merck | 1 | $3,300 |
| Medtronic | 1 | $147 |
| Tandem Diabetes Care, Inc. | 1 | $128 |
| Biomarin Pharmaceutical Inc. | 1 | $119 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$253,217
- SIMPONI$23,083
- NGENLA$8,442
- GENOTROPIN$1,848
- MINIMED 780G$147
- t:slim X2 Insulin Pump with Control-IQ$128
- VOXZOGO 1.2mg$119
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.